SEC Form 4 · accession 0000899243-16-034906
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Semigran
Officer — Chief Medical Officer
Period of report
Dec 1, 2016
Accepted (ET)
Dec 5, 2016 · 3:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $15.95 | Dec 1, 2016 | A | 175,000 | A | — | Nov 30, 2026 | Common Stock | 175,000 | 175,000 | D |
Explanation of responses
- F125% of the shares subject to this option shall vest and become exercisable on December 1, 2017, and the remaining shares subject to this option shall vest and become exercisable in 36 equal monthly installments thereafter. This option is subject to full acceleration of vesting with respect to all then-unvested shares in the event the reporting person's service relationship is terminated by the issuer or any successor without Cause (as defined in the issuer's 2015 Stock Option and Incentive Plan) within one year following the consummation of a Sale Event (as defined in the issuer's 2015 Stock Option and Incentive Plan).